Status:

COMPLETED

Clinical Evaluation of the Safety and Benefits of the Milesman 445 nm Blue Laser on Inflammatory Acne Lesions.

Lead Sponsor:

Gaias Salud

Collaborating Sponsors:

Gaias Research

Conditions:

Acne Vulgaris

LASER

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

Acne treatment by laser or other light devices is a currently accepted procedure. It allows faster resolution of injuries, with fewer side effects and greater patient satisfaction. The mechanism of a...

Detailed Description

Introduction / Justification Acne vulgaris (AV) is a polygenic multifactorial disease of the pilosebaceous units, which leads to the formation of both non-inflammatory lesions (comedones) and inflamma...

Eligibility Criteria

Inclusion

  • Adults between 18 and 50 years old
  • Diagnosis of mild to moderate acne on the face
  • They must have 10 - 50 inflammatory lesions (papules and pustules) on the face
  • In general good health

Exclusion

  • Allergies or light sensitivities.
  • Severe acne or pre-existing dermatological facial condition
  • Presence of cysts on the face
  • More than one nodule on the face
  • Having an uncontrolled disease or an immunodeficient disorder.
  • Being pregnant or lactating
  • Oral and / or topical antibiotic treatment in the last 2 weeks.
  • Current treatment with hormonal contraceptives.
  • Impossibility of avoiding excessive sun exposure and any light treatment or any similar pro-fessional or aesthetic procedure during the 15 days before and 15 days after treatment.
  • Previous history of poorly healed wounds, keloid formation, or bleeding disorders
  • Process of active or historical infection of herpes simplex.
  • Extreme sensitivity to hydroquinone or other bleaching agents.
  • Personal or family history of melanoma.
  • Dysplastic nevus.

Key Trial Info

Start Date :

September 24 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 15 2021

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04698239

Start Date

September 24 2020

End Date

February 15 2021

Last Update

March 15 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

GAIAS RESEARCH,C/PINTOR XAIME QUESADA Nº3

Santiago de Compostela, La Coruña, Spain, 15702